QIAGEN to propose initiation of annual cash dividend for shareholder approval at Annual General Meeting

Ad hoc Announcement according to Art. 17 Market Abuse Regulation

QIAGEN to propose initiation of annual cash dividend for shareholder approval at Annual General Meeting

Venlo, the Netherlands, May 7, 2025 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces that its Supervisory Board will propose the initiation of an annual cash dividend under an amended dividend policy to QIAGEN’s shareholders at the next Annual General Meeting scheduled for June 26, 2025.

This milestone reflects QIAGEN’s strategy to introduce a new avenue to increase shareholder returns while preserving flexibility to reinvest in long-term growth.

The Supervisory Board’s decision on the amended dividend policy and initial dividend payment is subject to approval by QIAGEN’s shareholders.

The initial dividend payment would consist of $0.25 per ordinary share. This proposal represents a total payout of about $54 million. The record date is currently planned for July 2, 2025, and the payment date as July 10, 2025. All dates will be confirmed following shareholder approval.

Under the amended dividend policy, QIAGEN would have the ability to submit an annual dividend proposal to the Annual General Meeting that contemplates returning capital to shareholders while supporting sustainable growth and maintaining creditworthiness. The respective dividend proposal would consider various factors, including the amount of capital returned to shareholders, the availability of distributable profits and reserves, investments in production and R&D, working capital requirements, and potential M&A opportunities.

QIAGEN N.V.

Hulsterweg 82

5912 PL Venlo

The Netherlands

ISIN: NL0015002CX3

Frankfurt Stock Exchange, Regulated Market (Prime Standard)

Contacts QIAGEN N.V.:

Corporate Communications

John Gilardi, Tel: +49 2103 29 11711; ir@qiagen.com